{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:22:56Z","timestamp":1782184976740,"version":"3.54.5"},"reference-count":21,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2023.12084","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:33:12Z","timestamp":1687951992000},"source":"Crossref","is-referenced-by-count":6,"title":["Anti\u2011PD1 therapy\u2011associated distal renal tubular acidosis: A case report"],"prefix":"10.3892","volume":"26","author":[{"given":"Xuejia","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingnan","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjun","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"key20230802124440_b1-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: Clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"key20230802124440_b2-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.7150\/jca.49174","article-title":"Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic review","volume":"12","author":"Ma","year":"2021","journal-title":"J Cancer"},{"issue":"3801","key":"key20230802124440_b3-ETM-26-2-12084","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat Commun"},{"key":"key20230802124440_b4-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4143\/crt.2020.790","article-title":"The pattern of time to onset and resolution of immune-related adverse events caused by immune checkpoint inhibitors in cancer: A pooled analysis of 23 clinical trials and 8,436 patients","volume":"53","author":"Tang","year":"2021","journal-title":"Cancer Res Treat"},{"key":"key20230802124440_b5-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.ekir.2020.04.018","article-title":"Immune checkpoint inhibitors and immune-related adverse renal events","volume":"5","author":"Herrmann","year":"2020","journal-title":"Kidney Int Rep"},{"key":"key20230802124440_b6-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s40620-021-01032-y","article-title":"Distal renal tubular acidosis: A systematic approach from diagnosis to treatment","volume":"34","author":"Giglio","year":"2021","journal-title":"J Nephrol"},{"key":"key20230802124440_b7-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1002\/cam4.4343","article-title":"Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database","volume":"10","author":"Hu","year":"2021","journal-title":"Cancer Med"},{"issue":"8408015","key":"key20230802124440_b8-ETM-26-2-12084","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8408015","article-title":"Renal tubular acidosis an adverse effect of PD-1 inhibitor immunotherapy","volume":"2018","author":"El Bitar","year":"2018","journal-title":"Case Rep Oncol Med"},{"key":"key20230802124440_b9-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ckj\/sfz051","article-title":"A new expression of immune checkpoint inhibitors' renal toxicity: When distal tubular acidosis precedes creatinine elevation","volume":"13","author":"Charmetant","year":"2019","journal-title":"Clin Kidney J"},{"key":"key20230802124440_b10-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.xkme.2020.05.015","article-title":"Renal tubular acidosis and immune checkpoint inhibitor therapy: An immune-related adverse event of PD-1 inhibitor-A report of 3 cases","volume":"2","author":"Herrmann","year":"2020","journal-title":"Kidney Med"},{"key":"key20230802124440_b11-ETM-26-2-12084","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2399369321992776","article-title":"A case of pembrolizumab induced distal renal tubular acidosis","volume":"5","author":"Atiq","year":"2021","journal-title":"J Onco Nephrol"},{"issue":"7406911","key":"key20230802124440_b12-ETM-26-2-12084","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7406911","article-title":"A rare presentation of checkpoint inhibitor induced distal RTA","volume":"2021","author":"Doodnauth","year":"2021","journal-title":"Case Rep Oncol Med"},{"key":"key20230802124440_b13-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00467-020-04693-2","article-title":"Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: An open-label comparative trial versus standard of care treatments","volume":"36","author":"Bertholet-Thomas","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"key20230802124440_b14-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00467-006-0249-5","article-title":"Is bicarbonate solution tolerated better than Shohl's solution in neonatal renal tubular acidosis?","volume":"22","author":"Uras","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"key20230802124440_b15-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/ndt\/gfs442","article-title":"Genetic causes and mechanisms of distal renal tubular acidosis","volume":"27","author":"Batlle","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key20230802124440_b16-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1152\/physrev.00045.2003","article-title":"Renal vacuolar H+-ATPase","volume":"84","author":"Wagner","year":"2004","journal-title":"Physiol Rev"},{"key":"key20230802124440_b17-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1056\/NEJM198803103181002","article-title":"The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis","volume":"318","author":"Batlle","year":"1988","journal-title":"N Engl J Med"},{"key":"key20230802124440_b18-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1681\/ASN.2017060643","article-title":"Extracellular adenosine stimulates vacuolar ATPase-dependent proton secretion in medullary intercalated cells","volume":"29","author":"Battistone","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"key20230802124440_b19-ETM-26-2-12084","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2016.08.029","article-title":"Purinergic signaling in kidney disease","volume":"91","author":"Menzies","year":"2017","journal-title":"Kidney Int"},{"issue":"716317","key":"key20230802124440_b20-ETM-26-2-12084","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716317","article-title":"Impact of antibiotics and proton pump inhibitors on efficacy and tolerance of anti-PD-1 immune checkpoint inhibitors","volume":"12","author":"Giordan","year":"2021","journal-title":"Front Immunol"},{"issue":"17588359221111703","key":"key20230802124440_b21-ETM-26-2-12084","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221111703","article-title":"Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"14","author":"Chen","year":"2022","journal-title":"Ther Adv Med Oncol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T12:44:46Z","timestamp":1690980286000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2023.12084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6,28]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2023.12084","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"article-number":"385"}}